Anti-CD48 antibodies, antibody drug conjugates, and uses thereof

TW202629611APending Publication Date: 2026-07-16NOVARTIS AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144951
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-24
Filing Date
2021-11-24
Publication Date
2026-07-16
Patent Text Reader

Abstract

Disclosed herein are antibodies, antigen binding fragments thereof, and antibody drug conjugates thereof that bind human CD48. Also disclosed are pharmaceutical compositions comprising the antibodies, antigen binding fragments thereof, and antibody drug conjugates thereof; and methods of making and using such pharmaceutical compositions for treating cancer in a patient in need of treatment.
Need to check novelty before this filing date? Find Prior Art